Trevor Page

Trevor leads GRAIL’s Biopharma Partnerships business with P&L responsibility for a portfolio of precision oncology programs with Biotech and Pharma partners. Prior to GRAIL, Trevor served as Chief Business Officer, Companion Diagnostics at Agilent Technologies. Trevor brings 25 years of diagnostic industry experience overseeing business development, alliance management, program management, product management, marketing, and new product introduction (NPI) commercial launch functions. Trevor earned a BA in Biological Sciences from the University of California at Santa Barbara as well as an MS in Biology and an MBA from San Diego State University.